作者
Xiaohui Pan,Hongbo He,Yuqian Bao,Yan Bi,Luyuan Chen,Xiaoping Chen,Hui Fang,Wenhuan Feng,Ling Gao,Lixin Guo,Yifang Guo,Yaling Han,Qi Hua,Nanfang Li,Quanmin Li,Yan Li,Yong Li,Xialian Li,Jing Liu,Huijuan Ma,Jianjun Mu,Kailei Nong,Hui Shang,Yunfeng Shen,Z.Q. Shi,Fang Sun,Ningling Sun,Jun Tao,Ji-Guang Wang,Xinling Wang,Jing Wu,Xinhua Xiao,Liangdi Xie,Jing Xu,Jing Xu,Hongying Ye,Dongni Yu,Hong Yuan,Huijie Zhang,Jian Zhang,Lili Zhang,Yuqing Zhang,Jiaqiang Zhou,Xinli Zhou,Dalong Zhu,Tiehong Zhu,Sheyu Li,Zhiming Zhu
摘要
Both hypertension and type 2 diabetes are attributable to premature death, cardiovascular and kidney diseases with largely overlapping population. Followed the GRADE approach, this expert consensus aimed to reduce the cardiovascular and kidney death and disability due to hypertension and minimize the treatment burden in adults with type 2 diabetes. Through online survey and discussion, a multidisciplinary team comprehensively prioritized seven key guideline questions. Informed by the evidence synthesis and online discussion, the team developed 12 recommendations under the GRADE Evidence-to-decision (EtD) framework. The recommendations covered the screening of hypertension in adults diagnosed with type 2 diabetes but not hypertension and the monitoring, lifestyle interventions, and medications in those diagnosed with type 2 diabetes and hypertension.